P&G reports fiscal 2026 sales of $87.0 billion, Q4 diluted EPS down 15%
Procter & Gamble reported fiscal 2026 fourth-quarter and full-year results, with Q4 organic sales flat and core EPS down 3% year over year while diluted EPS fell 15%. For the full fiscal year, organic sales rose 1% and core EPS increased 1%. The company posted $87.0 billion in revenue, supported primarily by favorable foreign exchange effects and higher pricing. A narrower gross margin and higher SG&A expenses weighed on profitability.